About this trial
The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if the device did not get opened and a pre-identified social support person or case manager when 2 or 7 consecutive days of nonadherence are detected, respectively. The investigators call our approach "A-Team" (Antiretroviral Therapy Electronic Adherence Monitoring). The aims of this application are to determine the acceptability and feasibility of real-time adherence monitoring in support persons and case managers of African American Men who have sex with Men and to test this approach for these men in a 6-month randomized controlled trial among 54 of these men living with HIV and measure ART adherence and viral suppression (the primary outcome).
Eligibility criteria
Qualifiers
AAMSM >18 years with self-reported HIV infection;
own a working cell phone;
on ART for at least 6 months;
have a case manager willing to participate in the study (for the clinical trial); and
Disqualifiers
Not meeting the inclusion criteria
Not agreeing to informed consent concerning interactions with research team, data collection, and access to medical records.
Candidates must provide consent to obtain a copy of their viral load results during the 12 months before and following study onset to confirm eligibility and explore long-term follow-up of possible effect.
Trial design
Treatments tested in this trial
- A-TEAM
Treatment groups
Sponsors and collaborators
University of Illinois at Chicago
Lead sponsor
Massachusetts General Hospital
Collaborator